1
/
of
0
FDA Drug Approval, N020411, CERVIDIL
FDA Drug Approval, N020411, CERVIDIL
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 020411
Company: FERRING PHARMS INC
Drug Name: CERVIDIL
Active Ingredients: DINOPROSTONE
Strength: 10MG
Dosage Form/Route: INSERT, EXTENDED RELEASE;VAGINAL
Action Date: 03/30/1995
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: FERRING PHARMS INC
Drug Name: CERVIDIL
Active Ingredients: DINOPROSTONE
Strength: 10MG
Dosage Form/Route: INSERT, EXTENDED RELEASE;VAGINAL
Action Date: 03/30/1995
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details